Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 25, 2021 - Issue 1
Submit an article Journal homepage
1,772
Views
5
CrossRef citations to date
0
Altmetric
Editorial

Glycans: potential therapeutic targets for cholangiocarcinoma and their therapeutic and diagnostic implications

Atit Silsirivanita Department of Biochemistry;b Faculty of Medicine, Center for Translational Medicine;c Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen, ThailandCorrespondence[email protected]
View further author information
Pages 1-4 | Received 11 Oct 2020, Accepted 04 Dec 2020, Published online: 18 Dec 2020

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Tomas Bertok, Veronika Pinkova Gajdosova, Aniko Bertokova, Natalia Svecova, Peter Kasak & Jan Tkac. (2021) Breast cancer glycan biomarkers: their link to tumour cell metabolism and their perspectives in clinical practice. Expert Review of Proteomics 18:10, pages 881-910.
Read now

Articles from other publishers (4)

Atit Silsirivanit. 2023. Glioblastoma - Current Evidence. Glioblastoma - Current Evidence.
Juthamas Khiaowichit, Chutima Talabnin, Chavaboon Dechsukhum, Atit Silsirivanit & Krajang Talabnin. (2022) Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways. Life 12:2, pages 174.
Crossref
Kay Ohlendieck & Dieter Swandulla. (2021) Complexity of skeletal muscle degeneration: multi-systems pathophysiology and organ crosstalk in dystrophinopathy. Pflügers Archiv - European Journal of Physiology 473:12, pages 1813-1839.
Crossref
Karuntarat Teeravirote, Sukanya Luang, Sakda Waraasawapati, Patcharee Boonsiri, Chaisiri Wongkham, Sopit Wongkham & Atit Silsirivanit. (2021) A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by Butea monosperma Agglutinin. Molecules 26:9, pages 2782.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.